Difficulty: Medium
Average Score: 86%
Practice
Blinatumomab, a bispecific T-cell engaging molecule, is active against which CD antigen that is expressed on B-lymphoblasts?
Correct answer
C
Rationale
Blinatumomab targets CD19-positive B-lymphoblasts by engaging CD3-positive T-cells.